Tulotta et al. demonstrated a dual role of IL1ß, where microenvironment-derived IL-1ß promoted the progression of breast cancer metastases in bone, whereas it inhibited the growth of primary tumor by recruiting innate immune cells with possible anti-tumor roles [140]. This evidence concerns the gene IL1B and neoplasm.